Drug Profile
Research programme: anti-infectives - NanoCyte
Alternative Names: Anti-infectives research programme - NanoCyteLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator NanoCyte
- Class Uracil nucleotides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Mycoses
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in Israel (Topical)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Mycoses in Israel (Topical)
- 06 Jun 2005 Preclinical trials in Bacterial infections in Israel (Topical)